Morgan Stanley Quoin Pharmaceuticals, Ltd. Transaction History

Morgan Stanley

  • $1.27 Trillion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$13.25 - $26.75 $1.44 Million - $2.91 Million
-108,890 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$22.38 - $232.38 $2.44 Million - $25.3 Million
108,890 New
108,890 $198,000

About Quoin Pharmaceuticals, Ltd.

QNRX Quotes by TradingView
  • Ticker QNRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,846,600
  • Market Cap $2.57M
  • Description
  • Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome. The company also offers three other pipeline products in development, which are also targe...
More about QNRX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email